Global Autologous Cell Therapy Market Analysis 2016-2020 and Forecast 2021-2026

  • Report ID:82160
  • Industry Name: Chemical & Material
  • Publishing Date: Apr-21
  • No. of Pages: 85
                              
Snapshot The global Autologous Cell Therapy market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Autologous Cell Therapy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Bone Marrow  Epidermis Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.): BioTime, Inc.  BrainStorm Cell Therapeutics  Caladrius Biosciences, Inc.  Fibrocell Science, Inc.  Opexa Therapeutics, Inc.  Pharmicell Co., Inc.  Regeneus Ltd.  TiGenix NV  TxCell SA  U.S. Stem Cell, Inc.  Vericel Corporation Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): Neurology  Orthopedics  Cancer  Wound Healing  CVD  Autoimmune  Others Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain etc.) Asia-Pacific (China, India, Japan, Southeast Asia etc.) South America (Brazil, Argentina etc.) Middle East & Africa (Saudi Arabia, South Africa etc.)
                        
Table of Contents Table of Contents 1 Industry Overview 1.1 Autologous Cell Therapy Industry Figure Autologous Cell Therapy Industry Chain Structure 1.1.1 Overview 1.1.2 Development of Autologous Cell Therapy 1.2 Market Segment 1.2.1 Upstream Table Upstream Segment of Autologous Cell Therapy 1.2.2 Downstream Table Application Segment of Autologous Cell Therapy Table Global Autologous Cell Therapy Market 2016-2026, by Application, in USD Million 1.2.3 COVID-19 Impact 1.3 Cost Analysis 2 Industry Environment (PEST Analysis) 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Autologous Cell Therapy Market by Type 3.1 By Type 3.1.1 Bone Marrow  Table Major Company List of Bone Marrow  3.1.2 Epidermis Table Major Company List of Epidermis 3.2 Market Size Table Global Autologous Cell Therapy Market 2016-2020, by Type, in USD Million Figure Global Autologous Cell Therapy Market Growth 2016-2020, by Type, in USD Million Table Global Autologous Cell Therapy Market 2016-2020, by Type, in Volume Figure Global Autologous Cell Therapy Market Growth 2016-2020, by Type, in Volume 3.3 Market Forecast Table Global Autologous Cell Therapy Market Forecast 2021-2026, by Type, in USD Million Table Global Autologous Cell Therapy Market Forecast 2021-2026, by Type, in Volume 4 Major Companies List 4.1 BioTime, Inc.  (Company Profile, Sales Data etc.) 4.1.1 BioTime, Inc.  Profile Table BioTime, Inc.  Overview List 4.1.2 BioTime, Inc.  Products & Services 4.1.3 BioTime, Inc.  Business Operation Conditions Table Business Operation of BioTime, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.2 BrainStorm Cell Therapeutics  (Company Profile, Sales Data etc.) 4.2.1 BrainStorm Cell Therapeutics  Profile Table BrainStorm Cell Therapeutics  Overview List 4.2.2 BrainStorm Cell Therapeutics  Products & Services 4.2.3 BrainStorm Cell Therapeutics  Business Operation Conditions Table Business Operation of BrainStorm Cell Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.3 Caladrius Biosciences, Inc.  (Company Profile, Sales Data etc.) 4.3.1 Caladrius Biosciences, Inc.  Profile Table Caladrius Biosciences, Inc.  Overview List 4.3.2 Caladrius Biosciences, Inc.  Products & Services 4.3.3 Caladrius Biosciences, Inc.  Business Operation Conditions Table Business Operation of Caladrius Biosciences, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.4 Fibrocell Science, Inc.  (Company Profile, Sales Data etc.) 4.4.1 Fibrocell Science, Inc.  Profile Table Fibrocell Science, Inc.  Overview List 4.4.2 Fibrocell Science, Inc.  Products & Services 4.4.3 Fibrocell Science, Inc.  Business Operation Conditions Table Business Operation of Fibrocell Science, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.5 Opexa Therapeutics, Inc.  (Company Profile, Sales Data etc.) 4.5.1 Opexa Therapeutics, Inc.  Profile Table Opexa Therapeutics, Inc.  Overview List 4.5.2 Opexa Therapeutics, Inc.  Products & Services 4.5.3 Opexa Therapeutics, Inc.  Business Operation Conditions Table Business Operation of Opexa Therapeutics, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.6 Pharmicell Co., Inc.  (Company Profile, Sales Data etc.) 4.6.1 Pharmicell Co., Inc.  Profile Table Pharmicell Co., Inc.  Overview List 4.6.2 Pharmicell Co., Inc.  Products & Services 4.6.3 Pharmicell Co., Inc.  Business Operation Conditions Table Business Operation of Pharmicell Co., Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.7 Regeneus Ltd.  (Company Profile, Sales Data etc.) 4.7.1 Regeneus Ltd.  Profile Table Regeneus Ltd.  Overview List 4.7.2 Regeneus Ltd.  Products & Services 4.7.3 Regeneus Ltd.  Business Operation Conditions Table Business Operation of Regeneus Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.8 TiGenix NV  (Company Profile, Sales Data etc.) 4.8.1 TiGenix NV  Profile Table TiGenix NV  Overview List 4.8.2 TiGenix NV  Products & Services 4.8.3 TiGenix NV  Business Operation Conditions Table Business Operation of TiGenix NV  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.9 TxCell SA  (Company Profile, Sales Data etc.) 4.9.1 TxCell SA  Profile Table TxCell SA  Overview List 4.9.2 TxCell SA  Products & Services 4.9.3 TxCell SA  Business Operation Conditions Table Business Operation of TxCell SA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.10 U.S. Stem Cell, Inc.  (Company Profile, Sales Data etc.) 4.10.1 U.S. Stem Cell, Inc.  Profile Table U.S. Stem Cell, Inc.  Overview List 4.10.2 U.S. Stem Cell, Inc.  Products & Services 4.10.3 U.S. Stem Cell, Inc.  Business Operation Conditions Table Business Operation of U.S. Stem Cell, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.11 Vericel Corporation (Company Profile, Sales Data etc.) 4.11.1 Vericel Corporation Profile Table Vericel Corporation Overview List 4.11.2 Vericel Corporation Products & Services 4.11.3 Vericel Corporation Business Operation Conditions Table Business Operation of Vericel Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 5 Market Competition 5.1 Company Competition Table Global Autologous Cell Therapy Sales Revenue 2016-2020, by Company, in USD Million Table Global Autologous Cell Therapy Sales Revenue Share 2016-2020, by Company, in USD Million Figure Global Autologous Cell Therapy Sales Revenue Share in 2020, by Company, in USD Million Table Global Autologous Cell Therapy Sales Volume 2016-2020, by Company, in Volume Table Global Autologous Cell Therapy Sales Volume Share 2016-2020, by Company, in Volume Figure Global Autologous Cell Therapy Sales Volume Share in 2020, by Company, in Volume 5.2 Regional Market by Company Figure North America Autologous Cell Therapy Market Concentration, in 2020 Figure Europe Autologous Cell Therapy Market Market Concentration, in 2020 Figure Asia-Pacific Autologous Cell Therapy MMarket Concentration, in 2020 Figure South America Autologous Cell Therapy Market Concentration, in 2020 Figure Middle East & Africa Autologous Cell Therapy Market Concentration, in 2020 6 Demand by End Market 6.1 Demand Situation 6.1.1 Demand in Neurology  Figure Autologous Cell Therapy Demand in Neurology , 2016-2020, in USD Million Figure Autologous Cell Therapy Demand in Neurology , 2016-2020, in Volume 6.1.2 Demand in Orthopedics  Figure Autologous Cell Therapy Demand in Orthopedics , 2016-2020, in USD Million Figure Autologous Cell Therapy Demand in Orthopedics , 2016-2020, in Volume 6.1.3 Demand in Cancer  Figure Autologous Cell Therapy Demand in Cancer , 2016-2020, in USD Million Figure Autologous Cell Therapy Demand in Cancer , 2016-2020, in Volume 6.1.4 Demand in Wound Healing  Figure Autologous Cell Therapy Demand in Wound Healing , 2016-2020, in USD Million Figure Autologous Cell Therapy Demand in Wound Healing , 2016-2020, in Volume 6.1.5 Demand in CVD  Figure Autologous Cell Therapy Demand in CVD , 2016-2020, in USD Million Figure Autologous Cell Therapy Demand in CVD , 2016-2020, in Volume 6.1.6 Demand in Autoimmune  Figure Autologous Cell Therapy Demand in Autoimmune , 2016-2020, in USD Million Figure Autologous Cell Therapy Demand in Autoimmune , 2016-2020, in Volume 6.1.7 Demand in Others Figure Autologous Cell Therapy Demand in Others, 2016-2020, in USD Million Figure Autologous Cell Therapy Demand in Others, 2016-2020, in Volume 6.2 Regional Demand Comparison Table Regional Demand Comparison List Table Major Application in Different Regions 6.3 Demand Forecast Table Autologous Cell Therapy Demand Forecast 2021-2026, by Application, in USD Million Figure Autologous Cell Therapy Market Growth 2021-2026, by Application, in USD Million Figure Autologous Cell Therapy Market Share in 2026, by Application, in USD Million Table Autologous Cell Therapy Demand Forecast 2021-2026, by Application, in Volume Table Autologous Cell Therapy Market Growth 2021-2026, by Application, in Volume Table Autologous Cell Therapy Market Share in 2026, by Application, in Volume 6.4 Impact of the COVID-19 on the Demand 7 Region Operation 7.1 Regional Production Table Autologous Cell Therapy Production 2016-2020, by Region, in USD Million Table Autologous Cell Therapy Production 2016-2020, by Region, in Volume 7.2 Regional Market Table Global Autologous Cell Therapy Market 2016-2020, by Region, in USD Million Table Global Autologous Cell Therapy Market Share 2016-2020, by Region, in USD Million Table Global Autologous Cell Therapy Market 2016-2020, by Region, in Volume Table Global Autologous Cell Therapy Market Share 2016-2020, by Region, in Volume 7.3 by Region 7.3.1 North America 7.3.1.1 Overview Figure North America Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million Figure North America Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 7.3.1.2 by Country (U.S., Canada, Mexico) Table North America Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million Table North America Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 7.3.2 Europe 7.3.2.1 Overview Figure Europe Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million Figure Europe Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) Table Europe Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million Table Europe Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 7.3.3 Asia-Pacific 7.3.3.1 Overview Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) Table Asia-Pacific Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million Table Asia-Pacific Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 7.3.4 South America 7.3.4.1 Overview Figure South America Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million Figure South America Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 7.3.4.2 by Country (Brazil, Argentina etc.) Table South America Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million Table South America Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 7.3.5 Middle East & Africa 7.3.5.1 Overview Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) Table Middle East & Africa Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million Table Middle East & Africa Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 7.4 Regional Import & Export 7.5 Regional Forecast Table Autologous Cell Therapy Market Forecast 2021-2026, by Region, in USD Million Table Autologous Cell Therapy Market Forecast 2021-2026, by Region, in Volume 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change Table Price Factors List 8.1.3 Manufacturers Gross Margin Analysis 8.2 Marketing Channel Figure Marketing Channels Overview 9 Research Conclusion
                
List of Table List of Table 1. Table Upstream Segment of Autologous Cell Therapy 2. Table Application Segment of Autologous Cell Therapy 3. Table Global Autologous Cell Therapy Market 2016-2026, by Application, in USD Million 4. Table Major Company List of Epidermis 5. Table Global Autologous Cell Therapy Market 2016-2020, by Type, in USD Million 6. Table Global Autologous Cell Therapy Market 2016-2020, by Type, in Volume 7. Table Global Autologous Cell Therapy Market Forecast 2021-2026, by Type, in USD Million 8. Table Global Autologous Cell Therapy Market Forecast 2021-2026, by Type, in Volume 9. Table BioTime, Inc.  Overview List 10. Table Business Operation of BioTime, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 11. Table BrainStorm Cell Therapeutics  Overview List 12. Table Business Operation of BrainStorm Cell Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 13. Table Caladrius Biosciences, Inc.  Overview List 14. Table Business Operation of Caladrius Biosciences, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 15. Table Fibrocell Science, Inc.  Overview List 16. Table Business Operation of Fibrocell Science, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 17. Table Opexa Therapeutics, Inc.  Overview List 18. Table Business Operation of Opexa Therapeutics, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 19. Table Pharmicell Co., Inc.  Overview List 20. Table Business Operation of Pharmicell Co., Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 21. Table Regeneus Ltd.  Overview List 22. Table Business Operation of Regeneus Ltd.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 23. Table TiGenix NV  Overview List 24. Table Business Operation of TiGenix NV  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 25. Table TxCell SA  Overview List 26. Table Business Operation of TxCell SA  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 27. Table U.S. Stem Cell, Inc.  Overview List 28. Table Business Operation of U.S. Stem Cell, Inc.  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 29. Table Vericel Corporation Overview List 30. Table Business Operation of Vericel Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 31. Table Global Autologous Cell Therapy Sales Revenue 2016-2020, by Company, in USD Million 32. Table Global Autologous Cell Therapy Sales Revenue Share 2016-2020, by Company, in USD Million 33. Table Global Autologous Cell Therapy Sales Volume 2016-2020, by Company, in Volume 34. Table Global Autologous Cell Therapy Sales Volume Share 2016-2020, by Company, in Volume 35. Table Regional Demand Comparison List 36. Table Major Application in Different Regions 37. Table Autologous Cell Therapy Demand Forecast 2021-2026, by Application, in USD Million 38. Table Autologous Cell Therapy Demand Forecast 2021-2026, by Application, in Volume 39. Table Autologous Cell Therapy Market Growth 2021-2026, by Application, in Volume 40. Table Autologous Cell Therapy Market Share in 2026, by Application, in Volume 41. Table Autologous Cell Therapy Production 2016-2020, by Region, in USD Million 42. Table Autologous Cell Therapy Production 2016-2020, by Region, in Volume 43. Table Global Autologous Cell Therapy Market 2016-2020, by Region, in USD Million 44. Table Global Autologous Cell Therapy Market Share 2016-2020, by Region, in USD Million 45. Table Global Autologous Cell Therapy Market 2016-2020, by Region, in Volume 46. Table Global Autologous Cell Therapy Market Share 2016-2020, by Region, in Volume 47. Table North America Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million 48. Table North America Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 49. Table Europe Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million 50. Table Europe Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 51. Table Asia-Pacific Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million 52. Table Asia-Pacific Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 53. Table South America Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million 54. Table South America Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 55. Table Middle East & Africa Autologous Cell Therapy Market Size 2016-2020, by Country, in USD Million 56. Table Middle East & Africa Autologous Cell Therapy Market Size 2016-2020, by Country, in Volume 57. Table Autologous Cell Therapy Market Forecast 2021-2026, by Region, in USD Million 58. Table Autologous Cell Therapy Market Forecast 2021-2026, by Region, in Volume 59. Table Price Factors List
List of Figure List of Figure 1. Figure Autologous Cell Therapy Industry Chain Structure 2. Figure Global Autologous Cell Therapy Market Growth 2016-2020, by Type, in USD Million 3. Figure Global Autologous Cell Therapy Market Growth 2016-2020, by Type, in Volume 4. Figure Global Autologous Cell Therapy Sales Revenue Share in 2020, by Company, in USD Million 5. Figure Global Autologous Cell Therapy Sales Volume Share in 2020, by Company, in Volume 6. Figure North America Autologous Cell Therapy Market Concentration, in 2020 7. Figure Europe Autologous Cell Therapy Market Market Concentration, in 2020 8. Figure Asia-Pacific Autologous Cell Therapy MMarket Concentration, in 2020 9. Figure South America Autologous Cell Therapy Market Concentration, in 2020 10. Figure Middle East & Africa Autologous Cell Therapy Market Concentration, in 2020 11. Figure Autologous Cell Therapy Demand in Neurology , 2016-2020, in USD Million 12. Figure Autologous Cell Therapy Demand in Neurology , 2016-2020, in Volume 13. Figure Autologous Cell Therapy Demand in Orthopedics , 2016-2020, in USD Million 14. Figure Autologous Cell Therapy Demand in Orthopedics , 2016-2020, in Volume 15. Figure Autologous Cell Therapy Demand in Cancer , 2016-2020, in USD Million 16. Figure Autologous Cell Therapy Demand in Cancer , 2016-2020, in Volume 17. Figure Autologous Cell Therapy Demand in Wound Healing , 2016-2020, in USD Million 18. Figure Autologous Cell Therapy Demand in Wound Healing , 2016-2020, in Volume 19. Figure Autologous Cell Therapy Demand in CVD , 2016-2020, in USD Million 20. Figure Autologous Cell Therapy Demand in CVD , 2016-2020, in Volume 21. Figure Autologous Cell Therapy Demand in Autoimmune , 2016-2020, in USD Million 22. Figure Autologous Cell Therapy Demand in Autoimmune , 2016-2020, in Volume 23. Figure Autologous Cell Therapy Demand in Others, 2016-2020, in USD Million 24. Figure Autologous Cell Therapy Demand in Others, 2016-2020, in Volume 25. Figure Autologous Cell Therapy Market Growth 2021-2026, by Application, in USD Million 26. Figure Autologous Cell Therapy Market Share in 2026, by Application, in USD Million 27. Figure North America Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million 28. Figure North America Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 29. Figure Europe Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million 30. Figure Europe Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 31. Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million 32. Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 33. Figure South America Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million 34. Figure South America Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 35. Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2016-2020, in USD Million 36. Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2016-2020, in Volume 37. Figure Marketing Channels Overview

Purchase Report

Single User 2980
Multi User 5960
Corporate User 5960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.